IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
about
Aspirin as adjunctive treatment for giant cell arteritisAspirin as adjunctive treatment for giant cell arteritisEssential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesisClinical practice. Giant-cell arteritis and polymyalgia rheumaticaThe immunopathology of giant cell arteritis: diagnostic and therapeutic implicationsStatin use in giant cell arteritis: a retrospective study.T cell-macrophage interactions and granuloma formation in vasculitis.IL-26 promotes the proliferation and survival of human gastric cancer cells by regulating the balance of STAT1 and STAT3 activationImmune mechanisms in medium and large-vessel vasculitis.Differential expression of IL-17, 22 and 23 in the progression of colorectal cancer in patients with K-ras mutation: Ras signal inhibition and crosstalk with GM-CSF and IFN-γIncreased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis.Giant cell arteritis: immune and vascular aging as disease risk factors.Giant Cell Arteritis: From Pathogenesis to Therapeutic Management.Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.Serum Cytokine Profile in Asian Indian Patients with Takayasu Arteritis and its Association with Disease Activity.Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab.Genetic component of giant cell arteritis.Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literature.MDS and GCA: a prognostic dilemma.Giant Cell Arteritis: Beyond Corticosteroids.Design of the tocilizumab in giant cell arteritis trial.An unusual case of aortic rupture after deployment of a bare stent in the treatment of aortic dissection in a patient with giant-cell arteritis.Protective Role of Mast Cells in Primary Systemic Vasculitis: A PerspectiveTolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells.Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis.Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients.Absence of Bacteria in the Temporal Arteries of Patients with Giant Cell Arteritis.Effect of recombinant Lactobacillus casei expressing interleukin-10 in dextran sulfate sodium-induced colitis mice.Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.Stroke associated with giant cell arteritis: a population-based study.The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway.Giant Cell Arteritis: Practical Pearls and Updates.Current and emerging therapies in large-vessel vasculitis.Checks and Balances in Autoimmune Vasculitis.Might Pentoxifylline Have a Role as Adjuvant Therapy for Patients with Giant Cell Arteritis?
P2860
Q24194497-F019D7C9-A13E-4EBE-80CF-4FA8BE2AA382Q24198176-559CCB85-2CD8-481F-B3CF-AF0DA6AC6908Q24315357-76FC050F-9491-42E3-95C8-19C7414D44C1Q27005821-38805DDA-EDD4-4571-A434-A4353AD87007Q27021465-7AE3DE3A-60E8-4A28-A513-3AAB7388A101Q33576127-C64026FC-F43E-4417-8406-DA04176A44E7Q34171890-31CB64CE-4F19-4D54-A4F4-462F798AD90BQ34737528-8FA20795-2253-412F-9BFF-1538376DDA91Q34777943-9440E221-3057-414F-9877-55D35D5F07DDQ34989005-DABEE445-78FC-444D-A98A-89FDF568F303Q35102137-929C640B-38F5-4696-BC58-93BE0CFA4E4EQ35617577-E366031A-5653-4DAF-9C67-4F074D49B932Q36992669-F69A29C6-DC56-44DA-A87D-34B07D2CCC2AQ37026218-904944A4-A814-45D3-AF3A-FE7F163F1F94Q37721330-879684A6-6BE4-4141-AF30-DD64C7242ECEQ38015743-682F8480-877E-4A29-A30B-32DBE97AE903Q38120699-83CE3302-8AEC-4EA8-B272-5B8E617FFAADQ38201692-7E06CAE9-0932-4B03-8090-8680B104D34CQ38529556-3095FA9D-4382-4B73-9307-39D4882C7E34Q38560322-0F0EB38D-5913-4F6A-9665-ADD14DCEF94DQ40195385-BA5363D1-E9E4-4F2C-A462-AD4B74EB2735Q40964246-62040409-A0E1-47D8-A844-284BAB9A4E94Q41526202-1EB27297-8C1C-482D-BCC4-41C27784A6F8Q42245452-FE569113-A49F-4B5F-BA3E-C5A3F1AAF34FQ42321741-48C2A646-DB76-400D-9D65-4FFBAA80FC84Q42380775-18A45F9E-C9F0-45CF-BE10-DDF0B7363896Q43117014-1D4AE379-689B-472C-9964-BB58314D5BC1Q43907875-362D5657-F677-46C8-A5B4-154E6CE4ADB6Q44298534-F3024A2E-2EBF-4A35-BE78-81F14D250AFCQ44736294-FD053148-E19C-4080-AD67-F273915B1A9FQ48099660-C3A274E8-05CC-417B-9BE5-B683F4060CAAQ49980652-59EDF13B-5285-487C-B9DE-6B99F603CE70Q50082820-635727CF-C227-4166-82B9-6E533A38DA6BQ51764698-7420E48C-DDF8-4CF8-A5BE-4C3D18627D98Q57780364-EF23568B-E577-4FE7-8FB6-82388DE8C61C
P2860
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
@ast
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
@en
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
@nl
type
label
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
@ast
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
@en
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
@nl
prefLabel
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
@ast
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
@en
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
@nl
P2093
P2860
P1476
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
@en
P2093
Brian R Younge
Cornelia M Weyand
Jörg J Goronzy
P2860
P356
10.1097/BOR.0B013E32833EE946
P577
2011-01-01T00:00:00Z